Researchers at the University of North Carolina at Chapel Hill and North Carolina State University have uncovered a novel approach to creating inhalable vaccines using nanoparticles that shows promise for targeting such lung-specific diseases as influenza, pneumonia and tuberculosis.
The University of North Carolina at Chapel Hill received a $100 million donation to the UNC Eshelman School of Pharmacy from alumni Fred Eshelman, founder and CEO of Pharmaceutical Product Development and founding chairman of Furiex Pharmaceuticals. The committment will be used to create a center within the pharmacy school named the Eshelman Institute for Innovation.
The University of North Carolina at Chapel Hill announced on Wednesday a $100 million commitment to the UNC Eshelman School of Pharmacy from Fred Eshelman, a 1972 graduate of the School, founder and former CEO of Pharmaceutical Product Development, and founding chairman of Furiex Pharmaceuticals.
The Center for Healthcare Supply Chain Research, HDMA’s nonprofit research foundation, and Genentech on Tuesday presented the 2014 Nexus Award for Lifetime Achievement to David Moody, Jr., CEO of Mutual Wholesale Drug Co.
Purdue University, the University of Missouri and the University of North Carolina were the beneficiaries of a $1.5 million grant program designed to expand community pharmacy residency programs for recent school graduates.
The number of unintentional deaths from overdosing on prescription opioid painkillers in 2007 was greater than those from heroin and cocaine combined, according to a new study by medical researchers at the University of North Carolina, Duke University and the Centers for Disease Control and Prevention, who in particular called such deaths among teenagers and adults a national epidemic.